Masuoka N, Zukeran A, Takemoto K, Wang D, Ishihara K
Toxicol Rep. 2020; 7:282-287.
PMID: 32071881
PMC: 7016158.
DOI: 10.1016/j.toxrep.2020.02.001.
Wang D, Masuoka N, Kira S
Environ Health Prev Med. 2011; 8(2):37-40.
PMID: 21432086
PMC: 2723317.
DOI: 10.1007/BF02897924.
Zmijewski J, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G
Am J Respir Crit Care Med. 2009; 179(8):694-704.
PMID: 19151196
PMC: 2668804.
DOI: 10.1164/rccm.200806-851OC.
Nakagawa S, Kataoka T, Mizuguchi Y, Yoshimoto M, Sakoda A, Nomura T
J Clin Biochem Nutr. 2008; 43(1):41-9.
PMID: 18648658
PMC: 2459251.
DOI: 10.3164/jcbn.2008042.
Kondo A, Miyazaki M, Pu H, Gao C, Namba M
In Vitro Cell Dev Biol Anim. 1999; 35(3):155-8.
PMID: 10476912
DOI: 10.1007/s11626-999-0018-4.
Enhanced liver injury in acatalasemic mice following exposure to carbon tetrachloride.
Wang D, Ishii K, Zhen L, Taketa K
Arch Toxicol. 1996; 70(3-4):189-94.
PMID: 8825676
DOI: 10.1007/s002040050259.
Prevention of mammary tumorigenesis in acatalasemic mice by vitamin E supplementation.
Ishii K, Zhen L, Wang D, Funamori Y, Ogawa K, Taketa K
Jpn J Cancer Res. 1996; 87(7):680-4.
PMID: 8698615
PMC: 5921155.
DOI: 10.1111/j.1349-7006.1996.tb00277.x.
Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB.
Reddy J, Bunyaratvej S, Svoboda D
J Cell Biol. 1969; 42(2):587-96.
PMID: 5792343
PMC: 2107684.
DOI: 10.1083/jcb.42.2.587.
Activity and stability of catalase in blood and tissues of normal and acatalasemic mice.
AEBI H, SUTER H, FEINSTEIN R
Biochem Genet. 1968; 2(3):245-51.
PMID: 5715189
DOI: 10.1007/BF01474764.
Nature of the heterozygote blood catalase in a hypocatalasemic mouse mutant.
FEINSTEIN R, Braun J, Howard J
Biochem Genet. 1968; 1(3):277-85.
PMID: 5707677
DOI: 10.1007/BF00485182.
Microbodies in experimentally altered cells. VII. CPID-induced hepatic microbody proliferation in the absence of significant catalase synthesis.
Reddy J, Chiga M, Bunyaratvej S, Svoboda D
J Cell Biol. 1970; 44(1):226-34.
PMID: 5409461
PMC: 2107780.
DOI: 10.1083/jcb.44.1.226.
Heat and urea stability of blood catalase of catalase-mutant mouse strains.
FEINSTEIN R, Howard J, Savol R
Experientia. 1971; 27(10):1152-3.
PMID: 5127856
DOI: 10.1007/BF02286892.
Acatalasemia in the mouse and other species.
FEINSTEIN R
Biochem Genet. 1970; 4(1):135-55.
PMID: 4986298
DOI: 10.1007/BF00484026.
Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
Reddy J
Am J Pathol. 1974; 75(1):103-18.
PMID: 4825610
PMC: 1910808.
Molecular location of the genetic lesion in the acatalasemic mouse.
FEINSTEIN R, JAROSLOW B, Howard J
Biochem Genet. 1972; 6(4):263-73.
PMID: 4666756
DOI: 10.1007/BF00486120.
Further evidence to suggest that microbodies do not exist as individual entities.
Reddy J, Svoboda D
Am J Pathol. 1973; 70(3):421-38.
PMID: 4120301
PMC: 1904008.
Acatalasemia.
Ogata M
Hum Genet. 1991; 86(4):331-40.
PMID: 1999334
DOI: 10.1007/BF00201829.
A quantitative genetic analysis of tissue-specific catalase activity in Mus musculus.
Schisler N, Singh S
Biochem Genet. 1991; 29(1-2):65-89.
PMID: 1883320
DOI: 10.1007/BF00578241.
Extrapulmonary effects of ozone whether in the presence of nitrogen dioxide or not.
Veninga T, Lemstra W
Int Arch Arbeitsmed. 1975; 34(3):209-20.
PMID: 1184201
DOI: 10.1007/BF01371742.
